Entering text into the input field will update the search result below

Pignatelli out at Biolase

Jun. 17, 2014 8:28 AM ETBIOLASE, Inc. (BIOL) StockBy: Douglas W. House, SA News Editor3 Comments
  • Federico Pignatelli resigns as Chairman and CEO of Biolase (NASDAQ:BIOL) subsequent to the June 12 ruling from the Delaware Supreme Court. He will continue as a member of the BOD along with Paul Clark, Dr. Fred Moll, Dr. Norman Nemoy, Jim Talevich and Jeff Nugent.
  • Mr. Clark is elected Chairman of the Board. He was formerly the CEO of ICOS. Before that, he was President of Abbott's Pharmaceutical Division.
  • Mr. Nugent will serve as interim CEO until a permanent Chief Executive is appointed.

Recommended For You

About BIOL Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BIOL--
BIOLASE, Inc.